INTERLEUKIN-40 AS A PREDICTIVE TOOL OF RESPONSE TO TREATMENT FOR INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES. CMN. 2024;6(2):3635-3642. Accessed August 22, 2025. http://cahiersmagellanes.com/index.php/CMN/article/view/633